APP
CRBP icon

Avantax Planning Partners’s Corbus Pharmaceuticals CRBP Stock Holding History

Avantax Planning Partners’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4
Closed -$1K – 465
2018
Q3 		$1K Buy
+4
New +$647 ﹤0.01% 1406
2018
Q2 		– Sell
-4
Closed -$1K – 483
2018
Q1 		$1K Buy
+4
New +$898 ﹤0.01% 1685

Other funds holding CRBP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Avantax Planning Partners's CRBP Position: Q4 2018 in Review

Avantax Planning Partners sold out of Corbus Pharmaceuticals (CRBP) in Q4 2018, closing a stake of 4 shares — an estimated $1K sold.

Avantax Planning Partners first reported a position in CRBP in Q1 2018 and held it in 2 quarters. The position peaked at $1K in Q3 2018. 83 funds tracked by Wall St. Rank hold CRBP as of Q4 2018.

  • Avantax Planning Partners reported no remaining Corbus Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Avantax Planning Partners sold 4 Corbus Pharmaceuticals shares in Q4 2018, an estimated $1K.
  • Avantax Planning Partners first reported a position in Corbus Pharmaceuticals in Q1 2018 and held it in 2 quarters.
  • Avantax Planning Partners's Corbus Pharmaceuticals position peaked at $1K in Q3 2018.
  • 83 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q4 2018.

Based on Avantax Planning Partners's 13F filing for Q4 2018, filed 14 Feb 2019.